http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010308489-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_815b6d87f20ccd4ee6e4588630d08726
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C2202-24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-042
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C7-04
filingDate 2010-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a18200215ed0929a836df163eab1c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beb85015004ca3c1f270c52bdb49f3a8
publicationDate 2015-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2010308489-C1
titleOfInvention Contact lens sets and methods to prevent or slow progression of myopia or hyperopia
abstract Methods for slowing progression of myopia or hyperopia of human patients include a step of providing contact lenses. The contact lenses have two or more refractive powers. A first refractive power provides clear visual acuity and a second refractive power provides a defocused retinal image to the human patient. The methods involve providing first and second sets of the contact lenses, the contact lenses of the second set have a different optical design than the contact lenses of the first set. With the present methods, an eye care practitioner is able to select one or more contact lenses from the second set of contact lenses based on one or more ocular parameters of the patient, one or more responses of the patient to the contact lens of the first set, or both, to provide an improved clinical benefit to the patient compared to the benefit provided by the first set of contact lenses.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9201250-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9541773-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9535263-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9575334-B2
priorityDate 2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008218687-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454605836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44146076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412748496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65442

Total number of triples: 26.